Acceleron Pharma Inc.

NASDAQ: XLRN · Real-Time Price · USD
178.75
0.00 (0.00%)
At close: Apr 24, 2025, 3:47 PM

Acceleron Pharma Cash Flow Statement

Financials in USD. Fiscal year is undefined.
Fiscal Year Q3 2021 Q2 2021 Q1 2021
Period Ending Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Net Income
-254.85M -223.63M -178.56M
Depreciation & Amortization
4.23M 3.97M 3.88M
Stock-Based Compensation
48.96M 45.52M 39.18M
Other Working Capital
1.52B 2.4B 2.81B
Other Non-Cash Items
178.3M -260.16M -300.37M
Deferred Income Tax
n/a n/a n/a
Change in Working Capital
-237.99M 241.03M 284.16M
Operating Cash Flow
-261.36M -193.26M -151.71M
Capital Expenditures
-5.2M -3.67M -4.7M
Cash Acquisitions
n/a n/a n/a
Purchase of Investments
-484.07M -561.17M -497.92M
Sales Maturities Of Investments
328.11M 294.66M 299.52M
Other Investing Acitivies
n/a n/a n/a
Investing Cash Flow
-161.16M -270.18M -203.1M
Debt Repayment
n/a n/a n/a
Common Stock Repurchased
n/a n/a n/a
Dividend Paid
n/a n/a n/a
Other Financial Acitivies
29.08M 516.12M 532.83M
Financial Cash Flow
29.08M 516.12M 532.83M
Net Cash Flow
-393.43M 52.68M 178.03M
Free Cash Flow
-266.56M -196.94M -156.4M